The topic selection oversight panel is mainly responsible for making the following decisions about topics that have been considered by the NICE team: selecting devices, diagnostics and digital health ...

TVB-009 (denosumab biosimilar) for treating postmenopausal osteoporosis in people aged 60 to 90 [TSID11807] Medicine Not selected TBC Sulthiame for treating self-limiting epilepsy with centrotemporal ...

The Discussion tool can be used to encourage users to share thoughts on course material with both instructors and their peers. Creating forums and topics in Brightspace is an effective way for users ...